weight loss injections & pcos - pt 2

Back by overwhelming demand, this follow-up Q&A with Consultant Endocrinologist Dr Ali Abbara dives deeper into GLP-1 receptor agonists and PCOS — practical answers on evidence, safety, access and real-world use.  You can watch Pt 1 here.

What we cover
  • Where GLP-1s fit in PCOS care alongside lifestyle and other treatments
  • Who may benefit, eligibility and realistic outcomes
  • Side effects, titration, monitoring and when to pause or stop
  • Interactions and special considerations including contraception and fertility planning
  • Weight change plateaus, regaining and long-term maintenance
  • Cardiometabolic risk, insulin resistance and non-weight outcomes
  • Access and equity in the NHS and private care
  • How management and attitudes of obesity need to change
  • Audience Q&A on common scenarios and myths

Who this is for
  • People with PCOS considering or using GLP-1s
  • Clinicians looking for concise, patient-centred answers
  • Researchers and commissioners interested in real-world questions
​HELP SUPPORT OUR WORK
​If you are able to help support our work by making a small donation, we would be hugely appreciative.
OTHER WEBINARS YOU MAY ENJOY

leave a comment